Latham & Watkins LLP represented eFFECTOR in the transaction, eFFECTOR Therapeutics, Inc. (eFFECTOR), a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here